All News

The AUA has issued a new policy for urologists providing in-office ancillary services.

The FDA has expanded the approved use of onabotulinumtoxinA (Botox) to treat adults with overactive bladder who cannot use or do not adequately respond to anticholinergic medications.

Measurements taken of PSA over time improve the accuracy of aggressive prostate cancer detection when compared to a single measurement of PSA, according to a recent study.

Two recent studies appear to shed light on the effect of smoking on bladder cancer outcomes and the role a certain protein plays in metastatic disease.

More than 3% of prostate biopsies are subject to medical errors or contamination, a recent study found.

Patients who receive medical expulsive therapy as initial management for renal colic incur significantly lower episode-related expenditures than those undergoing early endoscopic stone removal, but are significantly more likely to have return visits to the emergency department, report researchers from the University of Michigan, Ann Arbor.

A comprehensive retrospective study found little variation in outcome for low-risk prostate cancer patients among the major treatment types, although significant cost differences were observed.

Agents in the pipeline for the treatment of Peyronie’s disease and castration-resistant prostate cancer have moved closer to FDA approval, their developers reported.

Overall cancer death rates have continued to decline in the U.S. among both men and women, among all major racial and ethnic groups, and for all of the most common cancer sites, including prostate cancer, a recent national report shows.

Several urologists have been appointed to new posts across the country.

The lifetime risks of cancer from medical radiation may be overemphasized relative to more immediate health risks, according to a recent study.

The third and most recent update of the Partin tables takes into account an updated Gleason scoring system and may be more accurate for contemporary patients diagnosed with prostate cancer, researchers from Johns Hopkins University, Baltimore report.

Researchers at Dana-Farber Cancer Institute, Boston, have discovered a molecular switch that enables advanced prostate cancers to spread without stimulation by male hormones.

Patients who have inherited a specific common genetic variant develop bladder cancer tumors that strongly express a protein known as prostate stem cell antigen (PSCA), which is also expressed in many prostate and pancreatic tumors, say researchers from the National Cancer Institute, Bethesda, MD.

Abbott Laboratories has announced FDA clearance of a new testosterone test designed to accurately measure a wide range of testosterone levels seen in both men and women.

Online reviews of urologists tend to be positive, but this consensus is generally composed of only two or three patient scores per physician, researchers report.

Among rescue and recovery workers exposed to dust, debris, and fumes following the World Trade Center terrorist attack, there was an increased incidence of prostate and thyroid cancers and multiple myeloma, although it is not clear how big a factor medical screening and non-WTC risk factors contributed to these increases, according to a recent study.

Two new studies shed light on recent trends in prostate cancer screening.One study found that prostate cancer screening in men older than 74 years of age is overused, while another documented a decline in prostate and other preventive cancer screenings over the last 10 years, possibly due to disagreement over current screening guidelines.

Patients with muscle-invasive bladder cancer who undergo robot-assisted radical cystectomy may experience less blood loss and shorter hospital stays than those undergoing open cystectomy, results of a new randomized study indicate.

If least costly alternative (LCA) policies for certain prostate cancer drugs had not been rescinded in 2010, Medicare expenditures would have been reduced by more than $33 million over 1 year, a new government report suggests.

In May 2012, the United States Preventive Services Task Force (USPSTF) recommended against PSA testing in all men based upon a flawed analysis that overestimated the harms and underestimated the benefits of testing (Ann Intern Med 2012; 157:137-8).

After dozens of false starts and temporary "fixes," policymakers and pundits predict that in 2013, Congress will finally resolve many of the issues causing instability and uncertainty in the urologic community.

Medical expulsive therapy for the initial management of uncomplicated acute renal colic, with eventual uretereoscopy if needed, is associated with less resource utilization and lower 6-week costs than early surgery, say researchers from the University of Michigan, Ann Arbor.

Despite the continuing pressure in Washington to slash federal spending, efforts are under way to prevent cuts, and to even support increases, in graduate medical education funding in order to prevent serious shortages of physicians at a time when increased numbers of patients will be seeking care.

Drugs and devices in the pipeline from Auxilium Pharmaceuticals, Inc., Nymox Pharmaceutical Corp., Palatin Technologies, Inc., ProUroCare Medical Inc., Bioniche Life Sciences Inc., Tengion Inc., Aeterna Zentaris Inc., and Can-Fite BioPharma.

Urologists discuss the treatments that have most affected their practices.

Sifting through the data that came out of Urology Times' recently released "State of the Specialty" survey, it's clear that the issues most concerning to urologists relate to the business side of practicing medicine.